
    
      The purpose of this study is to compare the concentration of [6R] 5,10-methylene-THF,
      5-formyl-THF, 5-methyl-THF and THF in the tumor, in adjacent mucosa and in plasma in patients
      with colon cancer receiving two different does of Modufolin® and Levoleucovorin (Isovorin®),
      respectively (60 and 200 mg/m2).
    
  